Supriya Lifescience Ltd share price logo

Supriya Lifescience Ltd Share Price

(SUPRIYA)

₹597.44.68%

as on 04:01PM, 28 Feb 2025

bell
The current prices are delayed by 15 mins, login to check live prices.

Supriya Lifescience Ltd Performance

  • Day's Low

    Day's High

    ₹585.6
    Day's Price Range
    ₹626.6
  • 52 Week's Low

    52 Week's High

    ₹305.5
    52-Week Price Range
    ₹835.2
1 Month Return-17.16 %
3 Month Return-23.27 %
1 Year Return+ 72.63 %
Previous Close₹626.70
Open₹619.95
Volume3.14L
Upper Circuit-
Lower Circuit-
Market Cap₹4,808.04Cr

Supriya Lifescience Ltd Key Statistics

P/E Ratio

0

PEG Ratio

0

Market Cap

₹4,808.04 Cr

P/B Ratio

0

EPS

0

Dividend Yield

0

Sector

Pharmaceuticals

ROE

15.73

Supriya Lifescience Ltd Analyst Rating

based on 1 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 1 analysts offering long term price targets for Supriya Lifescience Ltd. An average target of ₹740

Source: S&P Global Market Intelligence

Supriya Lifescience Ltd Share analysis

Supriya Lifescience Ltd price forecast by 1 analysts

Upside of23.87%

High

₹740

Target

₹740.00

Low

₹740

Supriya Lifescience Ltd target price ₹740, a slight upside of 23.87% compared to current price of ₹597.4. According to 1 analysts rating.

Source: S&P Global Market Intelligence

Key events for Supriya Lifescience Ltd

  • Supriya Lifescience Reports Record Revenue Growth - 26 Feb, 2025

    Supriya Lifescience achieved its highest quarterly revenue of Rs 186 crore in Q3FY25, a 33% year-on-year increase, with net profit surging 57%. Exports contributed 85% of revenue, driven by strategic initiatives and expansion into regulated markets. The commissioning of the new Module E block enhances capacity, supporting future growth.
  • Positive Outlook for Supriya Lifescience Stock - 05 Feb, 2025

    Supriya Lifescience stock shows potential for a rebound after recent volatility. Analysts suggest buying on dips above ₹398, targeting ₹415, with a stop at ₹390.
  • Supriya Lifescience Announces Board Changes - 01 Feb, 2025

    Supriya Lifescience Limited announced the completion of terms for Independent Directors Kedar Karmarkar and Bhairav Chokshi, effective February 1, 2025. Dr. Ganapati Dadasaheb Yadav and Dr. Sunil Subhash Bhagwat were appointed as Additional Non-Executive Independent Directors on January 24, 2025.
  • Supriya Lifescience Advocates for Enhanced R&D Support - 31 Jan, 2025

    Dr. Saloni Wagh emphasizes the need for domestic manufacturing and R&D support in India. She advocates for extending the PLI scheme and allocating funds to life sciences to boost innovation and drug discovery.
  • Supriya Lifescience Target Price Raised to Rs 740 - 29 Jan, 2025

    KR Choksey recommends buying Supriya Lifescience with a target price of Rs 740, citing strong revenue growth in the Analgesic segment and improved profitability. EPS estimates for FY26E and FY27E have been raised, reflecting the company's strategic focus on new product launches and enhanced manufacturing capacity.

Insights on Supriya Lifescience Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, SUPRIYA has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, SUPRIYA stock has moved up by 72.6%

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 0.62% to 0.67% in Dec 2024 quarter

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 20.23% to 20.26% in Dec 2024 quarter

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 6.03% to 6.52% in Dec 2024 quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 68.30% of holdings in Dec 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 112.7% return, outperforming this stock by 69.9%

Supriya Lifescience Ltd Financials

Value in ₹ crore
Details2021202220232024
Total Assets₹445.76Cr (-)₹737.14Cr (↑65.37%)₹820.71Cr (↑11.34%)₹921.25Cr (↑12.25%)
Total Liabilities₹177.17Cr (-)₹121.45Cr (↓31.45%)₹121.25Cr (↓0.16%)₹105.88Cr (↓12.68%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow- (-)- (-)- (-)- (-)- (-)

Index Inclusions

BSE Healthcare

₹38,211.72

-2.19 (-854.91%)

BSE Small-Cap

₹43,082.90

-2.33 (-1028.74%)

S&P BSE AllCap

₹10,471.31

0.68 (71.07%)

Supriya Lifescience Ltd Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
68.3%
0.00
Foreign Institutions
6.52%
8.23
Mutual Funds
0.67%
7.83
Retail Investors
20.26%
0.15
Others
4.26%
-11.89

Supriya Lifescience Ltd Key Indicators

Details20202021202220232024
Return On Equity %60.4159.1834.3413.6715.73

Supriya Lifescience Ltd Earnings and Dividends

  • Supriya Lifescience Ltd Earnings Results

    Supriya Lifescience Ltd’s net profit jumped 57.03% since last year same period to ₹46.78Cr in the Q3 2024-2025. On a quarterly growth basis, Supriya Lifescience Ltd has generated 1.37% jump in its net profits since last 3-months.

    Read More about Earnings Results
  • Supriya Lifescience Ltd Dividends May,2024

    In the quarter ending March 2024, Supriya Lifescience Ltd has declared dividend of ₹0.80 - translating a dividend yield of 0.13%.

    Read More about Dividends

Supriya Lifescience Ltd Technicals Summary

Bearish

Neutral

Bullish

Bearish

Supriya Lifescience Ltd is currently in a Bearish trading position according to technical analysis indicators.

Supriya Lifescience Ltd Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
BUY₹4,808.04 Cr10.57%0.50NANA
BUY₹11,541.60 Cr-6.3%0.52₹602 Cr₹2,851 Cr
NA₹150.63 Cr55.12%0.51NANA
NA₹49.04 Cr9.71%0.68NANA
NA₹171.17 Cr81.39%0.58NANA

About Supriya Lifescience Ltd

Supriya Lifescience Limited is an Indian manufacturing company and supplier of active pharmaceutical ingredients (APIs). As of 31 March 2021, the company has offered 39 APIs with a focus on therapeutic segments such as antihistamines, analgesics, anaesthetics, vitamins, anti-asthmatics and anti-allergies. The company has consistently been the largest exporter of Chlorpheniramine Maleate and Ketamine Hydrochloride from India - 4555 and 6570 units, respectively - between Fiscal 2017 and 2020. Supriya Lifescience has sought approval for its products from international regulatory authorities including the USFDA, EUGMP and EDQM, and is supported by a modern manufacturing facility. Two new clean rooms are set to be powered up in the first quarter of Fiscal 2022. Over the years, the company has issued 3002400, 1626302, 9757804 Equity shares and increased its face value from Rs 10 to Rs 2 per share. In December 2021, Supriya Lifescience Limited conducted a Rs 700 crores public issue and the allotted shares were listed on BSE Ltd and NSE.

Share Price: ₹597.40 per share as on 28 Feb, 2025 04:01 PM
Market Capitalisation: ₹4,808.04Cr as of today
Listing date: 28 Dec, 2021
Chairperson Name: Satish Waman Wagh
OrganisationSupriya Lifescience Ltd
Headquarters
IndustryPharmaceuticals
E-voting on sharesClick here to vote

FAQs on Supriya Lifescience Ltd

What is Supriya Lifescience Ltd price today?

Supriya Lifescience Ltd share price today stands at ₹597.4, Open: ₹619.95, Previous Close: ₹626.7, High: ₹626.6, Low: ₹585.6, 52 Week High: ₹835.2, 52 Week Low: ₹305.5.

How to Buy Supriya Lifescience Ltd Share in India?

  • Get a PAN card
  • Open a Demat account
  • Open a Trading account
  • Link your Demat account to your Trading account
  • Fund your Trading account
  • Place an order to buy Supriya Lifescience Ltd shares

Is Supriya Lifescience Ltd listed on NSE?

Supriya Lifescience Ltd is listed on NSE

Is Supriya Lifescience Ltd listed on BSE?

Supriya Lifescience Ltd is listed on BSE

What are today's High and Low prices of Supriya Lifescience Ltd?

  • Today's highest price of Supriya Lifescience Ltd is ₹626.6.
  • Today's lowest price of Supriya Lifescience Ltd is ₹585.6.

What are today's traded volumes of Supriya Lifescience Ltd?

Today's traded volume of Supriya Lifescience Ltd(SUPRIYA) is 3.14L.

What is today's market capitalisation of Supriya Lifescience Ltd?

Today's market capitalisation of Supriya Lifescience Ltd(SUPRIYA) is ₹4808.04Cr.

What is the 52 Week High and Low Range of Supriya Lifescience Ltd?

Supriya Lifescience Ltd (SUPRIYA)
Price
52 Week High
₹835.2
52 Week Low
₹305.5

How much percentage Supriya Lifescience Ltd is down from its 52 Week High?

Supriya Lifescience Ltd (SUPRIYA) share price is ₹597.4. It is down -28.47% from its 52 Week High price of ₹835.2

How much percentage Supriya Lifescience Ltd is up from its 52 Week low?

Supriya Lifescience Ltd (SUPRIYA) share price is ₹597.4. It is up 95.55% from its 52 Week Low price of ₹305.5

What are the historical returns of Supriya Lifescience Ltd?

Supriya Lifescience Ltd (SUPRIYA)
Returns
1 Day Returns
-29.3%
1 Month Returns
-17.16%
3 Month Returns
-23.27%
1 Year Returns
72.63%